Aligos Therapeutics, Inc. ALGS Q1 2026 earnings

FAQ

When did Aligos Therapeutics, Inc. report Q1 2026 earnings?

Aligos Therapeutics, Inc. (ALGS) reported Q1 2026 earnings on May 7, 2026 after market close.

What were Aligos Therapeutics, Inc.'s Q1 2026 revenue and EPS?

Aligos Therapeutics, Inc. reported revenue of $2.8M and eps of $-2.21 for Q1 2026.

Did Aligos Therapeutics, Inc. beat estimates in Q1 2026?

Revenue beat the consensus estimate of $250.0K by $2.6M. EPS beat the consensus estimate of $-2.29 by $0.08.

How did Aligos Therapeutics, Inc.'s Q1 2026 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 810.0% from $311.0K a year earlier and eps declined 4.7% from $-2.11.

Where can I find Aligos Therapeutics, Inc.'s Q1 2026 SEC filings?

You can read the 8-K earnings release (0001171843-26-003156) and the 10-Q periodic report (0001193125-26-212001) directly on SEC EDGAR. The filing index links above go to sec.gov.